pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 3
    lucerastat
    lucerastat
    Fabry Disease Idorsia Pharmaceutical Ltd
  • Phase 2
    lucicebtide
    lucicebtide
    Esophageal Cancer Sapience Therapeutics Inc
  • Phase 2
    lucinactant
    lucinactant
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Lee's Pharmaceutical Holdings Ltd
  • Phase 2
← prev
page 227 of 271
next →
Pain89
Neurology1
ludotadipep
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FutureChem Co Ltd
  • Phase 2
    lufepirsen
    Nexagon (lufepirsen [INN])
    Persistent Corneal Epithelial Defects Amber Ophthalmics Inc
  • Marketed
    luliconazole
    Luzu (luliconazole)
    Tinea Corporis Bausch Health US LLC
  • Phase 2
    lumacaftor
    lumacaftor
    Subarachnoid Hemorrhage Qanatpharma AG
  • Marketed
    lumasiran
    Oxlumo (lumasiran)
    Primary Hyperoxaluria Type I$ALNY ALNYLAM PHARMACEUTICALS, INC.
  • Phase 2
    lunbotinib
    lunbotinib [INN]
    Non-Small Cell Lung Cancer Ellipses Pharma Ltd
  • pre_registration
    lunsotogene parvec
    lunsotogene parvec
    Deafness$REGN REGENERON PHARMACEUTICALS, INC.
  • Marketed
    lusutrombopag
    Mulpleta (lusutrombopag)
    Thrombocytopenia$SGIOF SHIONOGI & CO LTD
  • Phase 3
    lutadenovec autogene + sapecmeran autogene
    lutadenovec autogene + sapecmeran autogene
    Metastatic Colorectal Cancer Nexoplex Bio LLC
  • Phase 3
    lutetium (177Lu) rosopatamab tetraxetan
    lutetium (177Lu) rosopatamab tetraxetan [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$TLX Telix Pharmaceuticals Ltd
  • Phase 3
    lutetium (177Lu) zadavotide guraxetan
    lutetium (177Lu) zadavotide guraxetan
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Curium Midco Sarl
  • Marketed
    lutetium Lu 177 dotatate
    Lutathera (lutetium Lu 177 dotatate)
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Advanced Accelerator Applications SA
  • pre_registration
    lutetium Lu 177 edotreotide
    lutetium Lu 177 edotreotide
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) ITM Isotope Technologies Munich SE
  • Phase 2
    luvesilocin
    luvesilocin [INN]
    Post Partum Depression (Maternal Depression / Postnatal D… Reunion Neuroscience Inc
  • Phase 2
    luvixasertib
    luvixasertib [INN]
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Treadwell Therapeutics Inc
  • Phase 2
    luvomeran
    luvomeran
    Cystic Fibrosis$VERX Vertex, Inc.
  • Phase 2
    luvometinib
    luvometinib [INN]
    Neurofibromatoses Type I (Von Recklinghausen's Disease) Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • Preclinical
    lysergic acid diethylamide
    lysergic acid diethylamide [INN]
    Unspecified Psychiatric Disorders PharmaTher Holdings Ltd
  • Phase 3
    lysergide tartrate
    lysergide tartrate
    Major Depressive Disorder$DFTX Definium Therapeutics, Inc.
  • Marketed
    mNEXSPIKE
    mNEXSPIKE
    Coronavirus Disease 2019 (COVID-19)$MRNA Moderna, Inc.
  • pre_registration
    mRNA-1010
    Seasonal Influenza$MRNA Moderna, Inc.
  • Phase 1
    mRNA-1215
    Nipah Virus (NiV) Infections$MRNA Moderna, Inc.
  • Phase 1
    mRNA-1365
    Human Metapneumovirus Infections$MRNA Moderna, Inc.
  • Phase 3
    mRNA-1403
    Norovirus Infections$MRNA Moderna, Inc.
  • Phase 1
    mRNA-1574
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$MRNA Moderna, Inc.
  • Phase 1
    mRNA-1644
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$MRNA Moderna, Inc.
  • Phase 2
    mRNA-3705
    Methylmalonic Acidemia$MRNA Moderna, Inc.